The majority of previous studies demonstrated that deregulated E2F1 facilitates premalignant or transformed cells to acquire multiple hallmarks of cancer, such as limitless replicative potential, metabolic reprogramming, metastasis, and ADT resistance (39). Here, E2F1 is linked to cancer.